drugset / Trial / NCT06652997
SPH3348 Tablets in a Single-center, Randomized, Open-label, Single-dose, Two-period, Two-sequence Crossover Design Food Effect Study in Healthy Chinese Subjects
Phase 1
Completed
16 enrolled
West China Second University Hospital
Shanghai Pharmaceuticals Holding Co., Ltd · collab
RandomizedCrossoverOpen-labelOther
Summary
The goal of this clinical trial is to evaluate the pharmacokinetic (PK) characteristics of single oral doses of SPH3348 tablets in healthy subjects under fasting and fed conditions, as well as the impact of food on PK.
Timeline
- Start
- 2022-07-15
- Primary completion
- 2022-08-14
- Completion
- 2022-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SPH3348 | Unknown | 480 mg | Oral |
Indications
No indication recorded.